-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The presence of patients receiving solid organ transplant (SOT) of Clostridium difficile infection risk (CDI), however, for in SOT incidence and outcome recipients CDI little is known about C.
difficile infection
.
The purpose of this study was to investigate the incidence and outcome of Clostridium difficile infection (CDI) in patients receiving solid organ transplants .Infection in SOT This study aims to investigate the incidence and outcome of Clostridium difficile infection (CDI) (CDI) -related in
The study included 2003 Nian 4 Yue 1 to 2017 Nian 12 Yue 31 the date accepted in Ontario SOT all adults, the longest follow-up date for the 2020 Nian 3 Yue 31 Ri
.
The main result was admission to the hospital due to a CDI diagnosis
The study included 2003 Nian 4 Yue 1 to 2017 Nian 12 Yue 31 the date accepted in Ontario SOT all adults, the longest follow-up date for the 2020 Nian 3 Yue 31 Ri
The results showed that 10724 Ming SOT recipients with a median follow-up time was 5.
0 years
Cumulative probability of Clostridium difficile infection
Cumulative probability of Clostridium difficile infectionTrends in the incidence of Clostridium difficile infection in the annual cohort of solid organ transplant recipients
Trends in the incidence of Clostridium difficile infection in the annual cohort of solid organ transplant recipientsIn general, the study observed an upward trend in CDI in the annual cohort of SOT recipients .
After the transplant CDI -related mortality, late-onset CDI with early-onset CDI compared to higher risk of death .
These findings suggest that prevention strategies should not be limited to the first few months after transplantation, for SOT might reduce receptor comprehensive treatment of acute kidney injury risk factors CDI short- and long-term mortality after .
In general, the study observed an upward trend in the CDI CDI of the recipients in the annual cohort of SOT SOT recipients .
After transplantation, there is an upward trend .
After the transplant CDI CDI -related mortality, late onset associated with mortality, late-onset CDI CDI with early-onset and early-onset CDI CDI compared to higher risk of death .
In comparison, the risk of death is higher .
These findings suggest that prevention strategies should not be limited to the first few months after transplantation, prevention against against SOT SOT may reduce the overall treatment of acute kidney injury risk factors recipient of the comprehensive treatment of acute kidney injury risk factor receptors may reduce CDI Short-term and long-term mortality after CDI .
The short-term and long-term mortality rate afterwards .
References: Hosseini-Moghaddam SM, Luo B, Bota SE, et al.
Incidence and Outcomes Associated With Clostridioides difficile Infection in Solid Organ Transplant Recipients.
JAMA Netw Open.
2021;4(12):e2141089.
doi:10.
1001/jamanetworkopen.
2021.
41089References: Hosseini-Moghaddam SM, Luo B, Bota SE, et al.
Incidence and Outcomes Associated With Clostridioides difficile Infection in Solid Organ Transplant Recipients.
JAMA Netw Open.
2021;4(12):e2141089.
doi:10.
1001/jamanetworkopen.
2021.
41089 JAMA doi:10.
1001/jamanetworkopen.
2021.
41089 leave a message here
